CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 50 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,574,000 | -50.9% | 152,964 | -51.7% | 0.02% | -48.3% |
| Q3 2016 | $3,205,000 | -39.3% | 316,976 | -32.6% | 0.03% | -47.3% |
| Q2 2016 | $5,279,000 | -22.1% | 470,058 | -5.2% | 0.06% | -22.5% |
| Q1 2016 | $6,774,000 | -28.0% | 495,908 | 0.0% | 0.07% | -9.0% |
| Q4 2015 | $9,407,000 | +1.1% | 495,908 | 0.0% | 0.08% | -9.3% |
| Q3 2015 | $9,308,000 | +26.1% | 495,908 | 0.0% | 0.09% | +32.3% |
| Q2 2015 | $7,384,000 | -1.7% | 495,908 | 0.0% | 0.06% | +4.8% |
| Q1 2015 | $7,511,000 | +11.6% | 495,908 | -1.9% | 0.06% | -10.1% |
| Q4 2014 | $6,732,000 | +18.3% | 505,418 | +11.9% | 0.07% | -4.2% |
| Q3 2014 | $5,693,000 | +41.3% | 451,496 | +13.2% | 0.07% | +46.9% |
| Q2 2014 | $4,028,000 | – | 398,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |